{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T07:31:45Z","timestamp":1790839905713,"version":"4.1.0"},"reference-count":57,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Revue Neurologique"],"published-print":{"date-parts":[[2021,5]]},"DOI":"10.1016\/j.neurol.2020.07.001","type":"journal-article","created":{"date-parts":[[2020,8,14]],"date-time":"2020-08-14T21:38:26Z","timestamp":1597441106000},"page":"550-556","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":37,"title":["Clinical and genetic update of hereditary spastic paraparesis"],"prefix":"10.1016","volume":"177","author":[{"given":"P.","family":"Lallemant-Dudek","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Durr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neurol.2020.07.001_bib0290","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1111\/dmcn.12080","article-title":"An update on the prevalence of cerebral palsy: a systematic review and meta-analysis","volume":"55","author":"Oskoui","year":"2013","journal-title":"Dev Med Child Neurol"},{"key":"10.1016\/j.neurol.2020.07.001_bib0295","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1177\/1352458517751049","article-title":"ECTRIMS\/EAN Guideline on the pharmacological treatment of people with multiple sclerosis","volume":"24","author":"Montalban","year":"2018","journal-title":"Mult Scler"},{"key":"10.1016\/j.neurol.2020.07.001_bib0300","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1016\/S1474-4422(19)30235-2","article-title":"Hereditary spastic paraplegia: from diagnosis to emerging therapeutic approaches","volume":"18","author":"Shribman","year":"2019","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.neurol.2020.07.001_bib0305","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.parkreldis.2019.10.028","article-title":"Nationwide prevalence of primary dystonia, progressive ataxia and hereditary spastic paraplegia","volume":"69","author":"Hellberg","year":"2019","journal-title":"Parkinsonism Relat Disord"},{"key":"10.1016\/j.neurol.2020.07.001_bib0310","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1001\/jamaneurol.2013.1707","article-title":"Hereditary ataxia and spastic paraplegia in Portugal: a population-based prevalence study","volume":"70","author":"Coutinho","year":"2013","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.neurol.2020.07.001_bib0315","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1159\/000358801","article-title":"The global epidemiology of hereditary ataxia and spastic paraplegia: a systematic review of prevalence studies","volume":"42","author":"Ruano","year":"2014","journal-title":"Neuroepidemiology"},{"key":"10.1016\/j.neurol.2020.07.001_bib0320","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1001\/jamaneurol.2017.5121","article-title":"Efficacy of exome-targeted capture sequencing to detect mutations in known cerebellar ataxia genes","volume":"75","author":"Coutelier","year":"2018","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.neurol.2020.07.001_bib0325","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/j.neurol.2017.03.034","article-title":"Hereditary spastic paraplegia: more than an upper motor neuron disease","volume":"173","author":"Parodi","year":"2017","journal-title":"Rev Neurol"},{"key":"10.1016\/j.neurol.2020.07.001_bib0330","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1007\/s00439-015-1536-7","article-title":"Delving into the complexity of hereditary spastic paraplegias: how unexpected phenotypes and inheritance modes are revolutionizing their nosology","volume":"134","author":"Tesson","year":"2015","journal-title":"Hum Genet"},{"key":"10.1016\/j.neurol.2020.07.001_bib0335","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1136\/jnnp.37.1.8","article-title":"Str\u00fcmpell's familial spastic paraplegia: genetics and neuropathology","volume":"37","author":"Behan","year":"1974","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.neurol.2020.07.001_bib0340","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1111\/j.1365-2990.2004.00587.x","article-title":"The extent of axonal loss in the long tracts in hereditary spastic paraplegia","volume":"30","author":"Deluca","year":"2004","journal-title":"Neuropathol Appl Neurobiol"},{"key":"10.1016\/j.neurol.2020.07.001_bib0345","doi-asserted-by":"crossref","first-page":"3331","DOI":"10.1093\/brain\/awy285","article-title":"Spastic paraplegia due to SPAST mutations is modified by the underlying mutation and sex","volume":"141","author":"Parodi","year":"2018","journal-title":"Brain"},{"key":"10.1016\/j.neurol.2020.07.001_bib0350","doi-asserted-by":"crossref","first-page":"e0164623","DOI":"10.1371\/journal.pone.0164623","article-title":"Gait patterns in patients with hereditary spastic paraparesis","volume":"11","author":"Serrao","year":"2016","journal-title":"PLoS ONE"},{"key":"10.1016\/j.neurol.2020.07.001_bib0355","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.clinbiomech.2017.07.013","article-title":"Increased lower limb muscle coactivation reduces gait performance and increases metabolic cost in patients with hereditary spastic paraparesis","volume":"48","author":"Rinaldi","year":"2017","journal-title":"Clin Biomech (Bristol, Avon)"},{"key":"10.1016\/j.neurol.2020.07.001_bib0360","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/0924-980X(95)00109-X","article-title":"Leg muscle activation during gait in Parkinson's disease: adaptation and interlimb coordination","volume":"97","author":"Dietz","year":"1995","journal-title":"Electroencephalogr Clin Neurophysiol"},{"key":"10.1016\/j.neurol.2020.07.001_bib0365","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1007\/s12311-013-0533-4","article-title":"Lower limb antagonist muscle co-activation and its relationship with gait parameters in cerebellar ataxia","volume":"13","author":"Mari","year":"2014","journal-title":"Cerebellum"},{"key":"10.1016\/j.neurol.2020.07.001_bib0370","doi-asserted-by":"crossref","first-page":"e0158267","DOI":"10.1371\/journal.pone.0158267","article-title":"Coactivation of lower limb muscles during gait in patients with multiple sclerosis","volume":"11","author":"Boudarham","year":"2016","journal-title":"PLOS ONE"},{"key":"10.1016\/j.neurol.2020.07.001_bib0375","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1016\/j.expneurol.2014.06.011","article-title":"Hereditary spastic paraplegia: clinical-genetic characteristics and evolving molecular mechanisms","volume":"261","author":"Lo Giudice","year":"2014","journal-title":"Exp Neurol"},{"key":"10.1016\/j.neurol.2020.07.001_bib0380","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1093\/hmg\/11.2.153","article-title":"Spastin, the protein mutated in autosomal dominant hereditary spastic paraplegia, is involved in microtubule dynamics","volume":"11","author":"Errico","year":"2002","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.neurol.2020.07.001_bib0385","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1093\/hmg\/ddg004","article-title":"Mutations of SPG4 are responsible for a loss of function of spastin, an abundant neuronal protein localized in the nucleus","volume":"12","author":"Charvin","year":"2003","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.neurol.2020.07.001_bib0390","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1007\/s12311-016-0803-z","article-title":"Hereditary spastic paraplegia: clinical and genetic hallmarks","volume":"16","author":"de Souza","year":"2017","journal-title":"Cerebellum"},{"key":"10.1016\/j.neurol.2020.07.001_bib0395","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1038\/ejhg.2015.240","article-title":"SPG7 mutations explain a significant proportion of French Canadian spastic ataxia cases","volume":"24","author":"Choquet","year":"2016","journal-title":"Eur J Hum Genet"},{"key":"10.1016\/j.neurol.2020.07.001_bib0400","doi-asserted-by":"crossref","first-page":"e2679","DOI":"10.1212\/WNL.0000000000007606","article-title":"Loss of paraplegin drives spasticity rather than ataxia in a cohort of 241 patients with SPG7","volume":"92","author":"Coarelli","year":"2019","journal-title":"Neurology"},{"key":"10.1016\/j.neurol.2020.07.001_bib0405","doi-asserted-by":"crossref","first-page":"2980","DOI":"10.1093\/brain\/aws240","article-title":"Spastic paraplegia gene 7 in patients with spasticity and\/or optic neuropathy","volume":"135","author":"Klebe","year":"2012","journal-title":"Brain"},{"key":"10.1016\/j.neurol.2020.07.001_bib0410","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1083\/jcb.200304112","article-title":"Loss of m-AAA protease in mitochondria causes complex I deficiency and increased sensitivity to oxidative stress in hereditary spastic paraplegia","volume":"163","author":"Atorino","year":"2003","journal-title":"J Cell Biol"},{"key":"10.1016\/j.neurol.2020.07.001_bib0415","doi-asserted-by":"crossref","first-page":"4216","DOI":"10.1091\/mbc.e09-03-0218","article-title":"Autocatalytic processing of m-AAA protease subunits in mitochondria","volume":"20","author":"Koppen","year":"2009","journal-title":"Mol Biol Cell"},{"key":"10.1016\/j.neurol.2020.07.001_bib0420","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1212\/WNL.0000000000001369","article-title":"SPG7 mutations are a common cause of undiagnosed ataxia","volume":"84","author":"Pfeffer","year":"2015","journal-title":"Neurology"},{"key":"10.1016\/j.neurol.2020.07.001_bib0425","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1097\/WCO.0000000000000585","article-title":"Hereditary ataxias and paraparesias: clinical and genetic update","volume":"31","author":"Parodi","year":"2018","journal-title":"Curr Opin Neurol"},{"key":"10.1016\/j.neurol.2020.07.001_bib0430","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1002\/ana.24611","article-title":"Hereditary spastic paraplegia: clinicogenetic lessons from 608 patients","volume":"79","author":"Sch\u00fcle","year":"2016","journal-title":"Ann Neurol"},{"key":"10.1016\/j.neurol.2020.07.001_bib0435","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1093\/brain\/awx081","article-title":"A panel study on patients with dominant cerebellar ataxia highlights the frequency of channelopathies","volume":"140","author":"Coutelier","year":"2017","journal-title":"Brain"},{"key":"10.1016\/j.neurol.2020.07.001_bib0440","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.ajhg.2012.12.012","article-title":"Mutations in GBA2 Cause Autosomal-Recessive Cerebellar Ataxia with Spasticity","volume":"92","author":"Hammer","year":"2013","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.neurol.2020.07.001_bib0445","doi-asserted-by":"crossref","first-page":"105676","DOI":"10.1016\/j.clineuro.2020.105676","article-title":"New biallelic GBA2 variant in a patient with SPG46","volume":"191","author":"Spagnoli","year":"2020","journal-title":"Clin Neurol Neurosurg"},{"key":"10.1016\/j.neurol.2020.07.001_bib0450","unstructured":"Synofzik M, Hufnagel RB, Z\u00fcchner S. PNPLA6-Related Disorders n.d.:16."},{"key":"10.1016\/j.neurol.2020.07.001_bib0455","doi-asserted-by":"crossref","unstructured":"SPATACSIN mutations cause autosomal recessive juvenile amyotrophic lateral sclerosis | Brain | Oxford Academic n.d. https:\/\/academic.oup.com\/brain\/article\/133\/2\/591\/290773 [accessed July 1, 2020].","DOI":"10.1093\/brain\/awp325"},{"key":"10.1016\/j.neurol.2020.07.001_bib0460","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1093\/brain\/awv320","article-title":"ALS5\/SPG11\/KIAA1840 mutations cause autosomal recessive axonal Charcot-Marie-Tooth disease","volume":"139","author":"Montecchiani","year":"2016","journal-title":"Brain"},{"key":"10.1016\/j.neurol.2020.07.001_bib0465","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1093\/brain\/awm293","article-title":"Mutations in SPG11 are frequent in autosomal recessive spastic paraplegia with thin corpus callosum, cognitive decline and lower motor neuron degeneration","volume":"131","author":"Stevanin","year":"2008","journal-title":"Brain"},{"key":"10.1016\/j.neurol.2020.07.001_bib0470","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1212\/01.wnl.0000294327.66106.3d","article-title":"SPG11 mutations are common in familial cases of complicated hereditary spastic paraplegia","volume":"70","author":"Paisan-Ruiz","year":"2008","journal-title":"Neurology"},{"key":"10.1016\/j.neurol.2020.07.001_bib0475","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.nbd.2017.02.007","article-title":"Loss of spatacsin function alters lysosomal lipid clearance leading to upper and lower motor neuron degeneration","volume":"102","author":"Branchu","year":"2017","journal-title":"Neurobiol Dis"},{"key":"10.1016\/j.neurol.2020.07.001_bib0480","doi-asserted-by":"crossref","first-page":"3813","DOI":"10.1016\/j.celrep.2018.05.098","article-title":"Inhibition of lysosome membrane recycling causes accumulation of gangliosides that contribute to neurodegeneration","volume":"23","author":"Boutry","year":"2018","journal-title":"Cell Rep"},{"key":"10.1016\/j.neurol.2020.07.001_bib0485","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1038\/ejhg.2013.27","article-title":"Rapidly deteriorating course in Dutch hereditary spastic paraplegia type 11 patients","volume":"21","author":"de Bot","year":"2013","journal-title":"Eur J Hum Genet"},{"key":"10.1016\/j.neurol.2020.07.001_bib0490","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1002\/ana.21310","article-title":"Long-term course and mutational spectrum of spatacsin-linked spastic paraplegia","volume":"62","author":"Hehr","year":"2007","journal-title":"Ann Neurol"},{"key":"10.1016\/j.neurol.2020.07.001_bib0495","series-title":"Dysfonctions des lysosomes et neurod\u00e9g\u00e9n\u00e9rescence\u00a0: l\u2019exemple de la parapl\u00e9gie spastique de type SPG11. Thesis. Paris 6","author":"Boutry","year":"2017"},{"key":"10.1016\/j.neurol.2020.07.001_bib0500","unstructured":"Mutations in SPG11, encoding spatacsin, are a major cause of spastic paraplegia with thin corpus callosum | Nature Genetics n.d. https:\/\/www.nature.com\/articles\/ng1980 [accessed July 1, 2020]."},{"key":"10.1016\/j.neurol.2020.07.001_bib0505","doi-asserted-by":"crossref","first-page":"199","DOI":"10.3174\/ajnr.A5935","article-title":"\u201cEars of the Lynx\u201d MRI Sign Is Associated with SPG11 and SPG15 Hereditary Spastic Paraplegia","volume":"40","author":"Pascual","year":"2019","journal-title":"Am J Neuroradiol"},{"key":"10.1016\/j.neurol.2020.07.001_bib0510","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/j.jmb.2010.05.023","article-title":"The sacsin repeating region (SRR): a novel Hsp90-related supra-domain associated with neurodegeneration","volume":"400","author":"Anderson","year":"2010","journal-title":"J Mol Biol"},{"key":"10.1016\/j.neurol.2020.07.001_bib0515","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1093\/hmg\/ddu491","article-title":"Sacs knockout mice present pathophysiological defects underlying autosomal recessive spastic ataxia of Charlevoix-Saguenay","volume":"24","author":"Larivi\u00e8re","year":"2015","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.neurol.2020.07.001_bib0520","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1007\/s10048-008-0131-7","article-title":"ARSACS in the Dutch population: a frequent cause of early-onset cerebellar ataxia","volume":"9","author":"Vermeer","year":"2008","journal-title":"Neurogenetics"},{"key":"10.1016\/j.neurol.2020.07.001_bib0525","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/1750-1172-8-41","article-title":"Autosomal recessive spastic ataxia of Charlevoix Saguenay (ARSACS): expanding the genetic, clinical and imaging spectrum","volume":"8","author":"Synofzik","year":"2013","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.neurol.2020.07.001_bib0530","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1186\/s13023-018-0898-z","article-title":"From motor performance to participation: a quantitative descriptive study in adults with autosomal recessive spastic ataxia of Charlevoix-Saguenay","volume":"13","author":"Gagnon","year":"2018","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.neurol.2020.07.001_bib0535","unstructured":"Hereditary spastic paraplegia type 5: natural history, biomarkers and a randomized controlled trial | Brain | Oxford Academic n.d. https:\/\/academic.oup.com\/brain\/article\/140\/12\/3112\/4596575 [accessed March 26, 2020]."},{"key":"10.1016\/j.neurol.2020.07.001_bib0540","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1002\/ana.24633","article-title":"GSK3\u00df-dependent dysregulation of neurodevelopment in SPG11-patient induced pluripotent stem cell model","volume":"79","author":"Mishra","year":"2016","journal-title":"Ann Neurol"},{"key":"10.1016\/j.neurol.2020.07.001_bib0545","doi-asserted-by":"crossref","first-page":"914","DOI":"10.3389\/fnins.2018.00914","article-title":"Tideglusib Rescues Neurite Pathology of SPG11 iPSC Derived Cortical Neurons","volume":"12","author":"Pozner","year":"2018","journal-title":"Front Neurosci"},{"key":"10.1016\/j.neurol.2020.07.001_bib0550","doi-asserted-by":"crossref","first-page":"3026","DOI":"10.1172\/JCI24694","article-title":"Disease-related phenotypes in a Drosophila model of hereditary spastic paraplegia are ameliorated by treatment with vinblastine","volume":"115","author":"Orso","year":"2005","journal-title":"J Clin Invest"},{"key":"10.1016\/j.neurol.2020.07.001_bib0555","first-page":"72","article-title":"Microtubule-targeting drugs rescue axonal swellings in cortical neurons from spastin knockout mice","volume":"6","author":"Fassier","year":"2013","journal-title":"Dis Model Mech"},{"key":"10.1016\/j.neurol.2020.07.001_bib0560","doi-asserted-by":"crossref","first-page":"3","DOI":"10.3389\/fneur.2019.00003","article-title":"Management of hereditary spastic paraplegia: a systematic review of the literature","volume":"10","author":"Bellofatto","year":"2019","journal-title":"Front Neurol"},{"key":"10.1016\/j.neurol.2020.07.001_bib0565","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1007\/s00415-018-9129-8","article-title":"Urinary symptoms, quality of life, and patient satisfaction in genetic and sporadic hereditary spastic paraplegia","volume":"266","author":"Schneider","year":"2019","journal-title":"J Neurol"},{"key":"10.1016\/j.neurol.2020.07.001_bib0570","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1111\/ene.12839","article-title":"Non-motor symptoms in patients with hereditary spastic paraplegia caused by SPG4 mutations","volume":"23","author":"Servelhere","year":"2016","journal-title":"Eur J Neurol"}],"container-title":["Revue Neurologique"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0035378720306287?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0035378720306287?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T05:42:05Z","timestamp":1758519725000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0035378720306287"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5]]},"references-count":57,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2021,5]]}},"alternative-id":["S0035378720306287"],"URL":"https:\/\/doi.org\/10.1016\/j.neurol.2020.07.001","relation":{},"ISSN":["0035-3787"],"issn-type":[{"value":"0035-3787","type":"print"}],"subject":[],"published":{"date-parts":[[2021,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical and genetic update of hereditary spastic paraparesis","name":"articletitle","label":"Article Title"},{"value":"Revue Neurologique","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neurol.2020.07.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}]}}